SBMU, Pharmaceutical Research Sciences
  • Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About
    • Aim and Scope
    • Ownership & Management
    • Indexing
    • Editorial Team
  • New Submission
  • Author Guidelines
    • Guideline
    • Types of articles
    • Templates
    • Publication Fees
  • Policies and Process
    • Publication Policy
    • Peer Review Process
    • Open Access Policy
    • plagiarism
    • Archiving
    • Privacy Statement
    • Copyright Notice
    • Waiver policy
    • Complaints Policy
    • Post- Publication Discussions and Corrections Policy
    • Advertisement and Marketing
  • Issues
    • Current
    • Archives
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 1 No. 1 (2018): Pharmacy Updates 2018 (Congress Proceeding)
  4. Supplementary Issues: Reviews of books, journal, congress, other media Special issues, and Scientific news

Vol. 1 No. 1 (2018)

March 2018

Application of CRISPR-Cas9 genome editing system in biomedical studies: recent progress and future perspectives

  • Hamed barabadi
  • Atieh Hashemi

International Pharmacy Acta, Vol. 1 No. 1 (2018), 4 March 2018 , Page 34-35
https://doi.org/10.22037/ipa.v1i1.19918 Published: 2018-03-04

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction: Recent advances in genome engineering are starting a revolution in biological research. The clustered regularly interspaced short palindromic repeats (CRISPR) and its associated protein (Cas9) enables diverse manipulations of genome function. It has become a predictable and precise method of choice for genome engineering by specifying a 20-nt targeting sequence within its guide RNA. Regarding its simplicity, broad applicability, and high efficiency, CRISPR-Cas9 tool can be used in understanding of cellular mechanisms, generating animal models, correcting defective gene(s) causing diseases, cancer treatment, removal of bacterial/ viral infections, and in drug discovery. Moreover, the capability of CRISPRi to gene regulation without altering its function can be utilized for exceeding our knowledge of gene expression in prokaryotic and eukaryotic systems.

Results: In this lecture, the history and biology of CRISPR system were described firstly. Also, the applications of CRISPR-Cas9 in various ways, such as efficient generation of a wide variety of biomedical important cellular models as well as animal ones, modifying epigenomes, conducting genome-wide screens, labeling specific genomic loci in living cells, genome editing applications in xenotransplantation and endogenous gene expression regulation by an altered version of this system were reviewed. Moreover, we describe how this technology can be used as an antimicrobial or antiviral tool. However, this technology still needs optimization and will require a better understanding of how this system works on molecular level.

Conclusions: The broad applications of CRISPR-Cas9 technology in biological research will greatly advance our knowledge of basic biology as well as opening a door to treat a wide spectrum of human diseases.

Keywords:
  • CRISPR-Cas9, Genome editing, Applications, CRISPRi
  • PDF

How to Cite

barabadi, H., & Hashemi, A. (2018). Application of CRISPR-Cas9 genome editing system in biomedical studies: recent progress and future perspectives. International Pharmacy Acta, 1(1), 34–35. https://doi.org/10.22037/ipa.v1i1.19918
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 303 times
  • PDF Downloaded: 180 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors
  • For Librarians

Make a Submission

Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

Powered by OJSPlus